Once integration is completed, the partners plan to accelerate commercial rollout across India, anticipated in 2026.
Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs partner to bring PrecisionCHD test to India, aiming to address high heart ...
Cardio Diagnostics Holdings will partner with a longtime distribution leader in India and an Indian network of nearly 300 ...
InvestorsHub on MSN
Cardio Diagnostics shares jump after announcing first international expansion into India
Shares of Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) climbed about 9.3% in premarket trading on Wednesday after the company unveiled plans to expand into India, marking its first move beyond the U.
One of the strongest predictors of long-term mortality among patients undergoing a cardiac stress test is the need for a pharmacologic versus treadmill test, new data show. Moreover, although the risk ...
An AI-powered heart disease test from Chicago firm is expanding to its first international market. Learn more here.
Investing.com -- Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) stock rose 9.3% in premarket trading Wednesday after the company announced a strategic agreement to launch its PrecisionCHD test in India ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback